StreetAlpha.app
Home › Stocks › TMCI

Treace Medical Concepts, Inc. (TMCI)

$4.44
▲ +0.45%
LAST CLOSE · NOV 17

Treace Medical Concepts makes surgical systems and implants for correcting bunions and related midfoot deformities. It last closed at $4.44 on Nov 17, up 0.45% on the day. TMCI last reported earnings on Fri, Nov 6, 2026.

AI Auto Pilots
Is TMCI in one of our four AI portfolios? Sign in free to see

Key Stats

Last 12 months
Results
Revenue
$203.3M
−7.1% vs a year ago
Net income
−$55.8M
−27.4% margin
EPS (diluted)
−$0.85
Free cash flow
−$18.6M
−9.1% margin
Valuation
Market cap
$291.1M
65.6M shares
P/E
–
No P/E while losing money
Price to sales
1.4
Market cap over revenue
Dividend yield
None
No dividend in 12 months
Balance sheet
Cash & equivalents
$7.8M
At Sep 30
Debt
$56.3M
At Sep 30
Shareholder equity
$61.6M
Shares outstanding
65.6M
At Oct 30
Fiscal year endsDecember
ExchangeNasdaq
Financials history
FY2021: $94.4M$94.4MFY2021FY2022: $141.8M$141.8MFY2022FY2023: $187.1M$187.1MFY2023FY2024: $209.4M$209.4MFY2024FY2025: $212.7M$212.7MFY2025

From TMCI's SEC filings, latest 10-Q for the period ending Sep 30, 2026 (filed Nov 6). Last 12 months adds up the four latest quarters.

Last report
Nov 6
2026 · Before the open (BMO)
Reported EPS
-$0.19
vs -$0.25 est. · beat
Year-ago EPS
—
Not on file
Options-implied move
±29.4%
Priced in before that report
Analyst consensus
1 Buy
1 firm · not enough for a consensus
Loading…

Analyst Ratings & Price Targets

Analyst Ratings →
Ratings · 90 days
1 Buy
1firm
1 Buy0 Hold0 Sell
Only 1 firm rated TMCI in the past 90 days, not enough for a consensus
Average 12-month target
$6.50
▲ 46.4% upside

Based on 1 analyst who set a price target on TMCI in the past 90 days. The average target is $6.50, with a high of $6.50 and a low of $6.50, compared with the last close of $4.44.

Low $6.50Avg $6.50High $6.50
Blue marker: last close $4.44
Highest target$6.50
Average target$6.50
Lowest target$6.50
Latest rating changes
StifelUpgrade
Nov 9Buy$6.50
Truist SecuritiesTarget raised
Aug 10Hold$4 → $5
Truist SecuritiesMaintained
Jul 16Hold$4
DateFirmActionRatingPrice target
Nov 9StifelUpgradeBuy$6.50
Aug 10Truist SecuritiesTarget raisedHold$4 → $5
Jul 16Truist SecuritiesMaintainedHold$4
Loading…

Technical Analysis

TMCI · as of the Nov 17 close · updated after every close
Uptrend

The stock sits between its 20 and 50 day averages. It is 24% above its 200 day average, so the longer trend is still up. Momentum is improving (RSI 48). The nearest support is the 50 day average at $4.42, and the nearest resistance the swing high (Jun 12) at $4.47.

Short trendBullish
Long trendBullish
MomentumImproving
StretchNormal
VolatilityHigh, 10.0%/day
Key levels
$5.4052 week high+21.6%
$4.58Pivot R1+3.2%
$4.5720 day average+2.9%
$4.49Pivot+1.1%
$4.47Swing high (Jun 12)+0.7%
$4.44100 day average+0.0%
$4.44Last close
$4.4250 day average−0.5%
$4.38Swing low (Sep 21)−1.4%
$4.35Pivot S1−2.0%
$3.36200 day average−24.3%
$1.1752 week low−73.6%
Indicators
RSI (14)48.26Middle of its rangeNeutral
MACD0.13Above its signal lineBullish
Stochastic64.9Middle of its rangeNeutral
ADX (14)14.1No clear trend
Williams %R-48.9Oversold below −80, overbought above −20Neutral
CCI (20)-18.1Oversold below −100, overbought above 100Neutral
Rate of change+3.7%Change over 10 sessionsBullish
ATR (14)$0.45Typical daily range, 10.0% of price
MA 10Below
MA 20Below
MA 50Above
MA 100Above
MA 200Above
What happened before, for TMCI

What happened before

See how TMCI did after each of today's signals in the past: how often it was higher 10 sessions later, and the typical move, next to its usual record.

November seasonalityHow TMCI usually does this month. See Seasonality

Calculated from daily prices after each close. Signals describe the chart, not where the stock will go. Past patterns often fail. Not investment advice.

Seasonality

How TMCI has done in each calendar month: the average and median return, how often each month finished higher, and every year since 2021.

Loading…

See the stocks that usually rise in November →

Whale Options Flow

90D

No whale options trades in TMCI in the last 90 days.

Loading…

See today’s whale options flow across the market →

TMCI Institutional Ownership

Full report →
Fund sentiment · Q3 2026
Neutral
Strongly bearishNeutralStrongly bullish
  • ▼41 buying vs 66 selling
  • ●Held by funds +0.1 pts
  • ●Funds holding -1
  • ▲Superinvestors: 3 added, 1 cut
  • ●Put/call not meaningful
Q4 '24Q1 '25Q2 '25Q3 '25Q4 '25Q1 '26Q2 '26Q3 '26
Funds holdingHeld by funds %
Q3 2026This quarterLast quarterChange
Funds holding116117−0.9%
In funds' top 10110.0%
Held by funds48.8%48.6%+0.1 pts
New / increased17 / 2431 / 38−40.6%
Reduced / sold out48 / 1832 / 30+6.5%
Put/call ratio–0.00–
Top holders, biggest buyers and sellers, 8 quarters of charts and this season's filings so far.See TMCI institutional ownership →

From SEC Form 13F filings for Sep 30, 2026. What the filings show, not a forecast: positions can be up to 45 days old and leave out short sales.

AI Auto Pilots

Paper trading

StreetAlpha runs four autonomous AI traders powered by Anthropic's Claude. Each one reads options flow, dark pool prints, insider filings, sentiment, macro signals and technicals, then makes its own trading decisions in a paper portfolio. Every decision is logged and every trade is tracked, so you can see whether TMCI is in one of them and how their past TMCI trades turned out.

TMCI in the AI portfolios
Loading…

Macro & Market News

All StreetAlpha news →

StreetAlpha hasn't covered TMCI in an article yet. Here's the latest on the wider market.

About Treace Medical Concepts

Treace Medical Concepts is a medical technology company based in Ponte Vedra, Florida. It makes surgical systems, instruments and implants for treating bunions and related midfoot deformities. Its main product line is the Lapiplasty 3D Bunion Correction System, which is supported by options for midfoot correction, minimally invasive osteotomy procedures and great toe fusions. The company sells mainly in the United States to surgeons who treat foot and ankle conditions, including surgical podiatrists and orthopaedic foot and ankle surgeons.

Headquarters
Ponte Vedra, FL